| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
| (30) |
Priority: |
19.02.1999 US 253120
|
| (43) |
Date of publication of application: |
|
14.11.2001 Bulletin 2001/46 |
| (73) |
Proprietor: BLOCK DRUG COMPANY, INC. |
|
West Trenton, New Jersey 08628 (US) |
|
| (72) |
Inventors: |
|
- HERMS, James, K.
New York, NY 10003 (US)
- DODD, Gregory, P.
Hackensack, NY 07601 (US)
|
| (74) |
Representative: Morris, Miriam Elizabeth et al |
|
GlaxoSmithKline
Corporate Intellectual Property
980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB) |
| (56) |
References cited: :
WO-A-93/13748 GB-A- 2 227 660
|
CH-A- 654 202 US-A- 4 362 713
|
|
| |
|
|
|
|